lower disease burden after initial on off interval making another on cycle safer? At first blush this sound analogous to how we make mutant / resistant strains in the lab. If you are actually lowering disease burden, why not let the CAR-Ts persist? Not trying to be combative or obtuse, just trying to reason out the setting where an On/Off CAR-T would be necessary.